SOX2 is amplified in small-cell lung cancer

被引：0
|
作者：
机构：
来源：
Nature Reviews Clinical Oncology | 2012年 / 9卷 / 11期
关键词：
D O I：
10.1038/nrclinonc.2012.170
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：608 / 608
相关论文
共 50 条
  • [1] Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
    Rudin, Charles M.
    Durinck, Steffen
    Stawiski, Eric W.
    Poirier, John T.
    Modrusan, Zora
    Shames, David S.
    Bergbower, Emily A.
    Guan, Yinghui
    Shin, James
    Guillory, Joseph
    Rivers, Celina Sanchez
    Foo, Catherine K.
    Bhatt, Deepali
    Stinson, Jeremy
    Gnad, Florian
    Haverty, Peter M.
    Gentleman, Robert
    Chaudhuri, Subhra
    Janakiraman, Vasantharajan
    Jaiswal, Bijay S.
    Parikh, Chaitali
    Yuan, Wenlin
    Zhang, Zemin
    Koeppen, Hartmut
    Wu, Thomas D.
    Stern, Howard M.
    Yauch, Robert L.
    Huffman, Kenneth E.
    Paskulin, Diego D.
    Illei, Peter B.
    Varella-Garcia, Marileila
    Gazdar, Adi F.
    de Sauvage, Frederic J.
    Bourgon, Richard
    Minna, John D.
    Brock, Malcolm V.
    Seshagiri, Somasekar
    NATURE GENETICS, 2012, 44 (10) : 1111 - +
  • [2] Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
    Charles M Rudin
    Steffen Durinck
    Eric W Stawiski
    John T Poirier
    Zora Modrusan
    David S Shames
    Emily A Bergbower
    Yinghui Guan
    James Shin
    Joseph Guillory
    Celina Sanchez Rivers
    Catherine K Foo
    Deepali Bhatt
    Jeremy Stinson
    Florian Gnad
    Peter M Haverty
    Robert Gentleman
    Subhra Chaudhuri
    Vasantharajan Janakiraman
    Bijay S Jaiswal
    Chaitali Parikh
    Wenlin Yuan
    Zemin Zhang
    Hartmut Koeppen
    Thomas D Wu
    Howard M Stern
    Robert L Yauch
    Kenneth E Huffman
    Diego D Paskulin
    Peter B Illei
    Marileila Varella-Garcia
    Adi F Gazdar
    Frederic J de Sauvage
    Richard Bourgon
    John D Minna
    Malcolm V Brock
    Somasekar Seshagiri
    Nature Genetics, 2012, 44 : 1111 - 1116
  • [3] Mapping the SOX2 Functional Network in Small-Cell Lung Cancer
    Kamp, M. J. Vande
    May, D. G.
    Thompson, E.
    Wollenzien, H.
    Roux, K. J.
    Kareta, M. S.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S34 - S34
  • [4] Relationship of Sox2 and Rb in Tumor Initiation and Maintenance in Small-Cell Lung Cancer
    Voigt, E.
    Wollenzien, H.
    Thompson, E.
    Feiner, J.
    Kamp, M. Vande
    Kareta, M. S.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S35 - S35
  • [5] Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer
    Maddison, Paul
    Thorpe, Alison
    Silcocks, Paul
    Robertson, John F. R.
    Chapman, Caroline J.
    LUNG CANCER, 2010, 70 (03) : 335 - 339
  • [6] Sox2 Is an Oncogenic Driver of Small-Cell Lung Cancer and Promotes the Classic Neuroendocrine Subtype
    Voigt, Ellen
    Wallenburg, Madeline
    Wollenzien, Hannah
    Thompson, Ethan
    Kumar, Kirtana
    Feiner, Joshua
    McNally, Moira
    Friesen, Hunter
    Mukherjee, Malini
    Afeworki, Yohannes
    Kareta, Michael S.
    MOLECULAR CANCER RESEARCH, 2021, 19 (12) : 2015 - 2025
  • [7] Identification of Sox2 regulatory factors in small cell lung cancer
    Wollenzien, Hannah
    Yousef, Mira
    Voigt, Ellen
    Kareta, Michael S.
    CANCER RESEARCH, 2019, 79 (13)
  • [8] The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung
    Karachaliou, Niki
    Rosell, Rafael
    Viteri, Santiago
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (03) : 172 - 179
  • [9] Sox2 is required for tumor initiation and maintenance in small cell lung cancer
    Voigt, Ellen
    Thompson, Ethan
    Wollenzien, Hannah
    Kamp, Madeline Vande
    Kareta, Michael S.
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Immunohistochemical analysis of SOX2 expression in small-cell neuroendocrine carcinoma of the endometrium
    Ebisu, Yusuke
    Ishida, Mitsuaki
    Mizokami, Tomomi
    Kita, Masato
    Okada, Hidetaka
    Tsuta, Koji
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 13 (02) : 115 - 118
12345